| Pharmaceutical active ingredients: |
| Aliskiren FumarateHydrochlorothiazide |
| Available forms, composition and doses of Rasilez HCT: |
| Tablets, Film-Coated; Oral; Aliskiren Fumarate 150 mg; Hydrochlorothiazide 12.5 mgTablets, Film-Coated; Oral; Aliskiren Fumarate 150 mg; Hydrochlorothiazide 25 mgTablets, Film-Coated; Oral; Aliskiren Fumarate 300 mg; Hydrochlorothiazide 12.5 mgTablets, Film-Coated; Oral; Aliskiren Fumarate 300 mg; Hydrochlorothiazide 25 mg |
| Rasilez HCT medical category: |
| Human:Renin inhibitors |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C09XA52 - Aliskiren and Hydrochlorothiazide |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| NovartisFour StarZuellig Pharma |